A5102856333- Medical Imaging Techniques and Applications
- Radiomics and Machine Learning in Medical Imaging
- Cancer, Hypoxia, and Metabolism
- Advanced MRI Techniques and Applications
- Medical Imaging and Pathology Studies
- Radiopharmaceutical Chemistry and Applications
- MRI in cancer diagnosis
- Cardiac Imaging and Diagnostics
- Lymphoma Diagnosis and Treatment
- Lanthanide and Transition Metal Complexes
- Nanoplatforms for cancer theranostics
- Advanced X-ray and CT Imaging
- Cancer Treatment and Pharmacology
- Gastric Cancer Management and Outcomes
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Dementia and Cognitive Impairment Research
- Hepatocellular Carcinoma Treatment and Prognosis
- Lung Cancer Diagnosis and Treatment
- Drug Transport and Resistance Mechanisms
- Cancer, Lipids, and Metabolism
- Cardiac tumors and thrombi
- Cancer Research and Treatments
- Alzheimer's disease research and treatments
- Glioma Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
Saitama Medical University
2015-2025
Kobe City Medical Center General Hospital
2022-2025
Saitama Medical University Hospital
2019-2023
Foundation for Biomedical Research and Innovation
2009-2016
Saitama International Medical Center
2015-2016
Universitätsklinikum Würzburg
2016
Institute for Biomedical Research and Innovation
2011-2014
University of Würzburg
2014
IHI Corporation (United States)
2013
Daiyukai General Hospital
2002-2008
Eribulin mesylate (eribulin) is a first-in-class halichondrin B-based microtubule dynamics inhibitor. To compare the anti-angiogenic activity of eribulin to that bevacizumab, we compared tumour vessel remodelling and reoxygenation between two agents. Patients with advanced breast cancer stage III/IV were eligible for study. assigned receive either or single-agent bevacizumab. Tissue concentrations oxyhaemoglobin (O2Hb) deoxyhaemoglobin (HHb), oxygen saturation (SO2) tumours before day 7...
To investigate the improvement of prognostication active bone metastatic burden by discriminating metastases from degenerative changes in hot foci, using skeletal standardized uptake values (SUVs) quantitative single photon emission tomography/computed tomography (SPECT/CT) patients with prostate cancer.We investigated 170 cancer who underwent SPECT/CT 99mTc-methylene-diphosphonate (MDP), through conjugate gradient reconstruction tissue zoning, attenuation, and scatter corrections applied,...
Purpose: Bevacizumab, an antibody against endothelial growth factor, is a key but controversial drug in the treatment of metastatic breast cancer. We, therefore, aimed to determine intrinsic resistance bevacizumab at physiologic and molecular levels advanced cancer using PET, dynamic contrast-enhanced MRI, diffuse optical spectroscopic imaging (DOSI), multiplex cytokine assays.Experimental Design: In total, 28 patients diagnosed with stage III/IV receiving single-agent for 1 week followed by...
<h3>BACKGROUND AND PURPOSE:</h3> The role of <sup>18</sup>F-FDG-PET in the diagnosis Alzheimer disease is increasing and should be validated. aim this study was to assess inter-rater variability interpretation images obtained Japanese Alzheimer9s Disease Neuroimaging Initiative, a multicenter clinical research project. <h3>MATERIALS METHODS:</h3> This analyzed 274 scans (67 mild disease, 100 cognitive impairment, 107 normal cognitive) as baseline for which were acquired with various types...
This study aimed to evaluate the quality and associated quantitative values of bone single-photon emission computed tomography (SPECT) with without SwiftScan using a semiconductor camera equipped cadmium-zinc-telluride detector.
Hypoxia is a key driver of cancer progression. We evaluated the prognostic impact 18F-fluoromisonidazole (FMISO) prior to treatment in patients with breast cancer.Forty-four stage II/III primary underwent positron emission tomography/computed 18F-fluorodeoxyglucose (FDG-PET/CT) and FMISO. After measurement by FDG-PET/CT, tissue-to-blood ratio (TBR) was obtained using FMISO-PET/CT. FMISO-TBR compared for correlation clinicopathological factors, disease-free survival (DFS), overall (OS)....